Delivery Order SPE2DB20D1004-SPE2DB22FF5Q1
Award Date
4/25/22
Potential Completion Date
4/26/22
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The specific award is for the pharmaceutical product "TRELEGY ELLIPTA 100-62.5-25 60S", with a ceiling value of $2,186.26 and a completion...
This federal contract award is a delivery order with a ceiling value of $33,283.82, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication, with a performance period through April 26, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,460.94 firm-fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award, with a total ceiling value of $3,789.49, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award, valued at $3,637.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s, with a completion date of April 29, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of the pharmaceutical product Trelegy Ellipta 200-62.5-25 60S, a medication used for the treatment of respiratory conditions. The award has a ceiling value of $2,228.25 and is structured as a firm-fixed-price delivery order with an ultimate completion date of April 18, 2022. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a respiratory medication, with a...
This federal contract award is for the delivery of the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00, was issued to the prime contractor Cencora, Inc., doing business as Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to supply a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.99 firm fixed-price delivery order contract, with a completion date of February 4, 2025, is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a type of medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,313.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug Trelegy Ellipta 200-62.5-25 60S, a medication used for respiratory conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...